The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 07, 2026

Filed:

Jan. 05, 2021
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Nancy E. Lane, Hillsborough, CA (US);

Ruiwu Liu, Sacramento, CA (US);

Wei Yao, El Dorado Hills, CA (US);

Kit S. Lam, Davis, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/54 (2017.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 31/663 (2006.01); A61K 35/28 (2015.01); A61K 47/64 (2017.01);
U.S. Cl.
CPC ...
A61K 47/548 (2017.08); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 31/663 (2013.01); A61K 35/28 (2013.01); A61K 47/64 (2017.08);
Abstract

The present invention provides methods of treating a subject having a primary inflammatory disease or disorder comprising administering to the subject a composition comprising a conjugate of an LLP2A peptidomimetic ligand and a bisphosphonate drug, wherein the composition comprising the LLP2A-bisphosphonate conjugate enhances the delivery of mesenchymal stem cells to a site of inflammation. Methods of enhancing an anti-inflammatory or immunomodulatory property of mesenchymal stem cells, comprising administering to a subject in need thereof the mesenchymal stem cells and a composition comprising a conjugate of an LLP2A peptidomimetic ligand and a bisphosphonate drug, are also provided.


Find Patent Forward Citations

Loading…